Source: Investing.com ↗

AstraZeneca breast cancer drug fails late-stage trial goal

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

-0.01%

BTC/USDT

$86,094.00

+0.77%

ETH/USDT

$2,739.05

+0.38%

ZEC/USDT

$1,618.00

+6.58%

XRP/USDT

$1.61

+5.61%